Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

NCT05844982 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Radiation Retinopathy
Visual Impairment

Interventions

DRUG: Faricimab
DRUG: fluocinolone acetonide

Sponsor

Jaeb Center for Health Research

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]